Showing 1 - 10 of 26
Persistent link: https://www.econbiz.de/10005509115
There are three known criteria that underlie drug reimbursement decisions: therapeutic value, cost effectiveness and burden of disease. However, evidence from recent reimbursement decisions in several jurisdictions points to residual unexplained variables,_ one of which may be budget impact._ An...
Persistent link: https://www.econbiz.de/10005448991
Five years ago, cloud computing was one of the top emerging new technologies, nowadays it is almost common place. This rapid introduction of cloud business models in our society coincides with critical questions on the cloud’s risks, such as security and privacy. Moreover, there seems to be an...
Persistent link: https://www.econbiz.de/10014138090
The National Institute for Clinical Excellence has recently changed its guidelines on discounting costs and effects in economic evaluations. In common with most other regulatory bodies it now requires that health effects should be discounted at the same rate as costs. We show that the guideline...
Persistent link: https://www.econbiz.de/10005442745
Persistent link: https://www.econbiz.de/10009404224
This paper capitalizes on a first set of experiences on the application of multi-criteria decision analysis (MCDA) in seven low- and middle-income settings. It thereby reacts to a recent paper by Peacock et al., highlighting the potential of MCDA to guide policy makers in highly specific...
Persistent link: https://www.econbiz.de/10008871787
Persistent link: https://www.econbiz.de/10003516244
Considerations beyond cost-effectiveness are important in reimbursement decision making. We assessed the importance of disease severity in drug reimbursement decision making in Belgium, France, The Netherlands and Sweden. We investigated scientific literature and policy documents and conducted...
Persistent link: https://www.econbiz.de/10011190143
There is no scientific consensus on the optimal specification of the time trade-off (TTO) task. As a consequence, studies using TTO to value health states may share the core element of trading length of life for quality of life, but can differ considerably on many other elements. While this...
Persistent link: https://www.econbiz.de/10010845730
The results highlight that the instruments measure different constructs of QoL in children with ADHD. Despite this, the analyses showed comparable responsiveness and discriminative ability of the instruments. These results suggest that for economic evaluations, the EQ-5D is an appropriate and...
Persistent link: https://www.econbiz.de/10011151214